Abstract |
A case of invasive thymoma that responded well to the administration of a high-dose methylpredonisolone with cisplatin and adriamycin is reported. A 63-year-old woman was admitted to our hospital because of dyspnea, chest oppression and edema of the face. Chest CT revealed a large mass in the anterior mediastinum with the opacification of superior vena cava. Biopsy specimens from the mass revealed a spindle cell thymoma, consisting of epithelial cells and lymphoid cells. A diagnosis of invasive thymoma was made and the patient was intravenously treated with a high-dose of methylprednisolone (1000 mg on days 1-5 and 500 mg on days 6 and 7), cisplatin (80 mg/m2 on day 1) and adriamycin (40 mg/m2 on day 1). The treatment with three courses of this combined chemotherapy resulted in the improvement and regression of all clinical signs and symptoms. This case demonstrated that a high-dose methylprednisolone with cisplatin and adriamycin might be potentially effective for invasive thymoma.
|
Authors | Mitsutoshi Hayashi, Manako Taira, Isao Yamawaki, Shin-Ichiro Ohkawa |
Journal | Anticancer research
(Anticancer Res)
2006 Sep-Oct
Vol. 26
Issue 5B
Pg. 3645-8
ISSN: 0250-7005 [Print] Greece |
PMID | 17094379
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Doxorubicin
- Cisplatin
- Methylprednisolone
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Cisplatin
(administration & dosage)
- Dose-Response Relationship, Drug
- Doxorubicin
(administration & dosage)
- Female
- Humans
- Mediastinal Neoplasms
(diagnostic imaging, drug therapy)
- Methylprednisolone
(administration & dosage, therapeutic use)
- Middle Aged
- Thymoma
(diagnostic imaging, drug therapy)
- Tomography, X-Ray Computed
- Treatment Outcome
|